Press Releases

MYOS RENS Technology's Net Revenues Increase 114% and Operating Expenses Decrease 26% for the Three Months Ended June 30, 2020
MYOS RENS Technology Inc. Announces Settlement of Litigation with RENS Technology Inc.
University of California, Berkeley Researchers Publish Clinical Results Reporting that Fortetropin® Increased the Rate of Muscle Protein Synthesis in Older Adults
MYOS RENS Technology and MedAvail Inc. Announce Merger and Spin-Out of Muscle Health Business
MYOS RENS Launches RACE-Approved Continuing Education Course for Veterinarians on June 10, 2020
MYOS Announces Distribution Agreement with BodyLogicMD, a Leading Nationwide Network of Anti-Aging Medical Practices
MYOS RENS Partners with GetHealthy.store to Promote MYOS Longevity's Clinically-Backed Nutrition Products
MYOS RENS Enters into Agreement with Victor Medical to Distribute MYOS Canine Muscle Formula® Across Western United States
MYOS RENS Technology Reports First Quarter 2020 Financial Results Including a 95% Increase in Net Revenues
MYOS RENS Technology Announces the Date for First Quarter 2020 Conference Call and Webcast
RSS
Show All